China Medical System Holdings Ltd represents values of integrity, innovation, and excellence in the healthcare industry. With a commitment to providing high-quality pharmaceutical products and healthcare services, the company aims to cater to the medical needs of the Chinese market. China Medical System Holdings Ltd believes in fostering strong relationships with healthcare professionals and partnering with reputable international pharmaceutical companies to ensure the availability of advanced medical solutions. The corporate philosophy of the company centers around delivering sustainable growth and creating long-term value for shareholders while prioritizing the health and well-being of patients in China.

China Medical System Holdings Ltd (CMS) is primarily present in the People's Republic of China. As a leading specialty pharma company, CMS focuses on the marketing, promotion, and sales of innovative prescription and over-the-counter pharmaceutical products. With a strong presence in mainland China, CMS has established a widespread distribution network that covers both urban and rural areas. By leveraging its extensive market knowledge and relationships with healthcare providers, CMS effectively serves patients and contributes to improving healthcare standards in China.

China Medical System Holdings Ltd has achieved significant milestones since its establishment. The company has successfully expanded its product portfolio by establishing strategic partnerships with renowned pharmaceutical companies. It has also demonstrated impressive sales growth, leading to an increase in market share. China Medical System Holdings Ltd has consistently exhibited strong financial performance, with notable profitability and revenue growth. Additionally, the company has effectively implemented its marketing strategies, resulting in enhanced brand recognition and market penetration. These milestones reflect China Medical System Holdings Ltd's commitment to excellence and its position as a leading player in the pharmaceutical industry.

China Medical System Holdings Ltd is a leading pharmaceutical company in China, specializing in the marketing, promotion, and distribution of medical products. Established in 1995, the company has a rich history of over 25 years. China Medical System Holdings Ltd has successfully built relationships with numerous international pharmaceutical companies and local distributors to penetrate the Chinese market. With a focus on respiratory, cardiovascular, and infectious diseases, the company has achieved significant growth and expansion. Through its dedication to innovation, quality products, and strong partnerships, China Medical System Holdings Ltd has become a trusted name in the Chinese pharmaceutical industry.

The main competitors of China Medical System Holdings Ltd in the market are Shanghai Fosun Pharmaceutical Group Co., Ltd and Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. These companies provide similar healthcare products and services within China's medical industry. However, China Medical System Holdings Ltd has emerged as a strong player due to its unique product portfolio and strategic partnerships.

China Medical System Holdings Ltd is primarily active in the pharmaceutical industry. With its focus on marketing, distribution, and sales of medical and healthcare products, the company operates in various sectors, including Western medicines, Chinese medicines, and medical devices. China Medical System Holdings Ltd collaborates with international partners to bring innovative medications and therapies to the Chinese market, aiming to enhance the accessibility and quality of healthcare for the population. By leveraging its extensive network and expertise, the company strives to contribute to the advancement of medical care in China.

The business model of China Medical System Holdings Ltd revolves around being a pharmaceutical company focused on the marketing and distribution of branded products in China's prescription drug market. The company collaborates with multinational pharmaceutical companies and licenses their products for commercialization in China. With a strong network of regional distribution centers and sales offices, China Medical System Holdings Ltd effectively promotes and sells its portfolio of prescription drugs to hospitals, clinics, and pharmacies across the country. By strategically partnering with international pharmaceutical firms and utilizing its extensive distribution channels, the company aims to provide quality healthcare solutions to the Chinese market.

مُعامل القيمة السوقية إلى الأرباح لـ China Medical System Holdings هو ٩٫٧٥.

مُعامِل القيمة إلى المبيعات China Medical System Holdings هو ٢٫٢١.

نقاط جودة AlleAktien لـ China Medical System Holdings هي 7/10.

المتوقعة China Medical System Holdings الإيرادات هي ٧٫٩٠ مليارات CNY.

صافي الربح المتوقعة China Medical System Holdings هو ١٫٧٩ مليارات CNY.

China Medical System Holdings Ltd (CMS) is a Chinese company specializing in the manufacturing, distribution, and marketing of pharmaceutical products. It was founded in 1995 and is headquartered in Shenzhen, China. CMS is listed on the Hong Kong Stock Exchange and is one of the leading suppliers of drugs in China. CMS divides its portfolio into three segments: innovative products, classics, and other products. Innovative products include drugs developed by CMS or its subsidiaries. Classics are generic drugs that are already established in the Chinese market and are generally used to treat chronic conditions. Other products include dietary supplements and medical devices. CMS also operates a distribution network consisting of sales teams in each province of China. These teams work closely with doctors, pharmacists, and hospitals to market products to end consumers. CMS also has a strong online presence and sells its products through e-commerce platforms such as Tmall and JD.com. CMS works closely with academics and researchers to advance product development. The company also operates its own research center focusing on the exploration of new drugs and technologies. CMS has partnered with other companies and research institutions in China and worldwide to drive innovation in the field of medicine. Another important business area for CMS is the licensing of products from other countries. The company has partnered with international pharmaceutical companies such as AstraZeneca and Roche to market their products in China. CMS has also partnered with Japanese company Kaneka Corporation to distribute their products in China. CMS has experienced strong growth in recent years and aims to expand internationally. The company has already opened branches in Hong Kong, Taiwan, Macau, and the United States, and plans to expand its presence in other countries. CMS has also announced plans to expand into other areas such as diagnostics and medical technology. In summary, the business model of China Medical System Holdings Ltd focuses on the manufacturing, marketing, and distribution of drugs, dietary supplements, and medical devices. The company has a strong online presence, a distribution network in every province of China, and works closely with other companies and research institutions to drive innovation. CMS has experienced strong growth in recent years and plans to expand internationally.

يوزع China Medical System Holdings أرباحًا قدرها ٠٫٦٢ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ China Medical System Holdings في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـChina Medical System Holdings هو KYG211081248.

رمز WKN لـ China Medical System Holdings هو A1JLYP.

الرمز المُختصر لـ China Medical System Holdings هو 867.HK.

خلال آخر 12 شهراً، دفعت China Medical System Holdings توزيعات أرباح بقيمة ٠٫٦٢ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٨٫٦٦ %. ومن المتوقع أن تدفع China Medical System Holdings خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٦٩ CNY.

نسبة توزيعات الأرباح الحالية لـ China Medical System Holdings هي ٨٫٦٦ %.

China Medical System Holdings يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يونيو, يونيو, سبتمبر, سبتمبر.

China Medical System Holdings دفعت توزيعات الأرباح كل عام خلال الـ17 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٦٩ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٩٫٥٨ %.

China Medical System Holdings يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠٢ CNY من China Medical System Holdings المُعلن عنها في ٩‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٣٠‏/٨‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٩‏/٩‏/٢٠٢٤.

في العام 2023، وزعت China Medical System Holdings ٠٫٦١٦ CNY كأرباح أسهم.

يتم توزيع أرباح China Medical System Holdings بالعملة CNY.